Serial

microRNAs in Diabetes and Obesity is the world’s first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in the field on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in smallRNA world as well as commercial technological reports. Our goal is to have microRNAs in Diabetes and Obesity as a widest platform for miRNA research in Diabetes and Obesity.  The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.

microRNAs in Diabetes and Obesity is a first speciality journal in the newly emerging area of small, non-coding RNAs. Considering the increasing prevalence of diabetes and obesity all over the world, this is an apt addition to the scientific community. The journal editors are committed to transparent, comprehensive and rapid reviewing of manuscripts. Excellent editorial staff support provides the opportunity to all authors for a fast review process wherein the first response would be generally between 2 to 4 weeks of submission. All manuscripts are submitted online through the manuscript submission system and are guaranteed immediate attention. All accepted manuscripts are corrected for language suitability by our highly trained language editors.

Lastly, the journal offers a unique publishing concept that there are no journal issues. This means less waiting time for accepted articles from being allocated to specific issues. The volume numbers will be allocated every year and articles accepted for publication will be uploaded immediately on the journal website.

All of this presents microRNAs in Diabetes and Obesity as a unique platform for authors to submit, publish and share their work to the scientific community.

microRNAs in Diabetes and Obesity is the world’s first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in the field on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in smallRNA world as well as commercial technological reports. Our goal is to have microRNAs in Diabetes and Obesity as a unique platform for microRNA research in Diabetes and Obesity.  The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.

• Journal Editor: Anandwardhan A. Hardikar, The University of Sydney, Sydney, Australia

• Editors

Journal Editor

Anandwardhan A. Hardikar

ahardikar@versita.com

Editorial Office

Versita Ltd.

ul. Solipska 14a/1

02-482 Warsaw, Poland

Phone: +48 22 701 50 15